TriNetX

“The TriNetX platform is brilliant,” Dr. Wolf summed up. “Instead of spending days digging through medical records to come up with the right question to ask, I can do the same thing in a fraction of the time with TriNetX. I absolutely love the platform and what it can do for us.”

“The opportunity costs to do a study are just so low because of the efficiency of the platform. We plan on developing questions, doing the research, and getting to the truth using this giant database.”

“The TriNetX platform sets up perfectly for them because they don’t need an extensive amount of training. They are incented to publish a paper for their CV and the TriNetX platform has enabled us to help them reach that goal.”

“Using TriNetX, the analysis is almost done,” said Dr. Wolf. “Traditionally the real struggle in research has been gathering the data. Now the data is already gathered so we are able to spend more time thinking about the questions to analyze because the analysis itself is extremely fast. Was the analysis set up properly? Do the terms used best support answering the medical or biological question you’re asking?”

“I was absolutely amazed to find that the TriNetX platform has data from nearly 200,000 burn patients with better granularity than any of the other datasets we could use.”

“I quickly realized I could use this type of platform to access data on millions of patients with a reasonable degree of granularity and wouldn’t have to fight through an institutional review board to get it because the data is all de-identified. I knew then it would be a godsend.”

“TriNetX has been instrumental in helping us answer these questions in a reasonable amount of time.”

“Using the TriNetX platform for feasibility and then leveraging the data to pursue grant funding is something that we are really excited about,”

“They make it easy to accomplish what we need.”

“Thanks to the intuitive TriNetX interface, even though we didn’t have any experience with queries, we were able to easily formulate the query, and identify the participants very quickly.”

“Our previous experience on a similar project with an analysis of 20 million records exploring a kidney specific condition took three or four years to complete. Compared to three months, the difference with TriNetX is like night and day.”

“What we found in TriNetX is a partner that made it easy to obtain, explore, and analyze data, and then quickly move to insights,”

“This is really the major challenge that TriNetX solved with a wonderful, easy to use, and intuitive exploration platform.”

“TriNetX Research provides a world of opportunities to Penn State investigators,” said Neal Thomas, Associate Dean for Clinical Research at Penn State College of Medicine.”

“Collaboration in research is key and a major focus of the Clinical and Translational Science Award Program. Joining the larger TriNetX Research network gives us an opportunity to expand our research community,” said Katoch.”

“Penn State Clinical and Translational Science Institute works to make the research process more efficient at the university. TriNetX Research fits the institute’s mission well and its large set of real-world data enables our investigators to answer research questions more efficiently. TriNetX Research provides us with a tool that can assist Penn State researchers in the important process of translating research into new treatments and interventions.”

“Our relationship with TriNetX is awesome,” Katoch summed up. “Everyone on the TriNetX team is helpful and responsive. If I have questions, I get immediate answers, often within minutes.”

““TriNetX is a great company to work with and this has been a great partnership for MetroHealth,” Dr. Kaelber summed up. “So much of the time technology companies tend to overpromise and under-deliver, but TriNetX delivers on what they promise. They’ve exceeded my expectations.””

““I think the best way to quantify the performance of TriNetX is through the results we’ve seen,” said Dr. Kaelber. “We’ve published an important paper on COVID-19 and our clinical study opportunities have increased by the dozens.””

“This study would have been impossible to do without TriNetX,” said Dr. Kaelber. “Other networks we could have used weren’t mapping COVID-specific data so we couldn’t find the signal there or in our own system data. Besides, the results would be statistically insignificant because we wouldn’t have had enough patients.”

“The number one value proposition of the TriNetX proposal was about making us more visible to the research community,” said Dr. Kaelber. “It’s been a dream come true for us. We are getting an average of one to two study opportunities per week that we never would have heard about before. The pipeline of studies TriNetX has exposed us to is amazing. It’s been a 20- to 30-fold increase of opportunities compared to what we were getting from many other sources we tried.”

“TriNetX also improves our credibility,” Dawson continued. “Let’s say we’re working with a new medic in a hospital on a new disease area. If we say we can get so many people for a study we can now back that up with data, thanks to TriNetX.”

“The TriNetX platform has provided us a lot of efficiency savings as a site,” said Dawson. “The manual work of getting into the nitty gritty of an inclusion/exclusion criteria for a protocol really slows things down. TriNetX has trimmed that time down and made things much more refined. The way we can connect with other sites has been appealing.”

“TriNetX obviously enables us to do that. Building relevant queries ourselves means we don’t have to go backwards and forwards with coding and experiencing the delays that go with that.”

“TriNetX has helped us show the appeal of our Trust and that expanded framework has gotten more projects coming through sooner.”